Apellis Pharmaceuticals, Inc.

China Universal Asset Management Co., Ltd. APLS

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/27/2026

Shares

22,684

Value ($000)

913

Weight

0.1%

2025 Q2 - 2026 Q1 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/27/2026	913	0.1%	22,684	3/31/2026
2025 Q4	1/29/2026	518	0.0%	20,617	12/31/2025
2025 Q3	11/10/2025	501	0.0%	22,137	9/30/2025
2025 Q2	8/28/2025	437	0.0%	25,243	6/30/2025